Atlas Trials

Phase Ⅲ Trial of WBRT Versus Erlotinib Concurrent Whole-brain Radiation Therapy as first-line Treatment for Patients With Multiple Brain Metastases From Non-small-cell Lung Cancer(ENTER): a Multicentre, Open-label, Randomised Study

Clinical trial NCT01887795 · COMPLETED

Trial details

NCT number
NCT01887795
Sponsor
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Multiple Brain MetastasesNon-small-cell Lung Cancer
Start date
2013-08-01
Primary completion
2016-08-01
Enrollment
224

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.